TABLE 2.
Passage no. | Selection pressure (μM)a | EC50b (μM) | 2Apro mutation |
---|---|---|---|
00 | 0.6 ± 0.1 | No mutation | |
01 | 0.5 | 1.1 ± 0.4 | NDc |
02 | 1 | ND | ND |
03 | 2 | 2.9 ± 0.2 | No mutation |
04 | 4 | ND | ND |
05 | 8 | >30 (resistant) | N84T |
US/KY/14-18953 (MOI, 0.1) was treated with telaprevirat the indicated concentrations.
EC50s were quantified using the CPE assay and are means ± SEs.
ND, not determined.